# Future-Pharma-ETF
Team: Matthew Willson, Oodaye Shukla, Michael Ayres

Project description:
Integrate financial data from the top 50 pharmaceutical companies listed on the NYSE.
Build an index from this list of companies that optimizes the overall return from this collection of stocks.
The optimization process will incoroprate machine learning and other optimization techniques.
The input data will consist of asset prices, stock & financial performance metrics, alternate data including non-financial information such as sentiment, news, social media, adverse events, clinical trials, environment, and geopolitical events.
